Micro-Doppler Radar: A Gold Standard Comparison

NCT ID: NCT05521126

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

181 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-21

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a group who has not had the surgery to see if the micro-Doppler radar technology can accurately and predictably tell the difference.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this research is to validate that radar MDS can accurately and predictably differentiate individuals at high-risk for MSKI from those who are low risk. The investigators hypothesize that MDS will identify individuals at a high-risk for MSKI more accurately than the gold-standard MC technologies. To test this hypothesis, the investigators propose a case control study that will compare adults who have undergone ACL reconstruction to a control group of healthy adults that has not. Patients who have undergone ACL reconstruction have a 6-24% chance of either re-tearing their ACL or having a subsequent knee surgery on either side within two years of successful completion of surgery and post-surgical rehabilitation. Despite being released for full activities, little is known about what makes this group at high-risk for re-tear. As such, the investigators will use this patient population as a model for identifying an at-risk population for musculoskeletal injury (MSKI). The researchers will simultaneously collect radar micro-Doppler signals and biomechanical motion capture (MC) data in a state-of-the-art human movement lab. Participants will be asked to perform a series of functional activities that will be captured by both the MDS radar and MC systems. The data sets will then be analyzed independently.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Injury Anterior Cruciate Ligament Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

high risk/ACL repair cohort

The high risk cohort will be subjects who have had an ACL reconstruction procedure 9-24 months prior to enrollment.

No interventions assigned to this group

control group

The control group will be individuals who have not had an ACL reconstruction procedure.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

High risk cohort

* age 18-40
* history of ACL reconstruction
* no current musculoskeletal injuries
* ACL repair between 9 and 24 months prior to recruitment

Control cohort

* age 18-40
* never had lower extremity surgery

Exclusion Criteria

High risk cohort

* age \<18 or \>40
* pregnancy
* institutionalization
* history of cerebral vascular accident
* unable to provide informed consent
* inability to perform study activities
* history of hip or knee replacement
* inability to walk or jump without a limp
* current neuromuscular disease
* any surgery in the last 6 months

Control cohort

* age \< 18 or \> 40
* pregnancy
* institutionalization
* history of Cerebral Vascular Accident
* unable to provide informed consent
* inability to perform study activities
* history of knee or hip replacement
* inability to walk or jump without a limp
* current neuromuscular disease
* history of lower extremity surgery
* any surgery in the last 6 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

Lebanon Valley College

UNKNOWN

Sponsor Role collaborator

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cayce Onks

Associate Professor of Family Medicine and Orthopaedics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cayce A Onks, DO, MS

Role: PRINCIPAL_INVESTIGATOR

Milton S. Hershey Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lebanon Valley College

Annville, Pennsylvania, United States

Site Status

Pennsylvania State University College of Medicine

Hershey, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDMRP-OR210069

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

STUDY00020118

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RIIP REPS Neuromuscular Training
NCT07221305 COMPLETED NA